Clinical Trials
This section provides information about recently completed clinical trials. If you cannot find information about a particular clinical trial, you should note that results may not be available even after the trial ends. Some trials end before completion and results are never published.
Latest Clinical Trial Results
"Peripheral Blood Mononuclear Cells Engineered with mRNA Encoding Chimeric Tumor Antigen Receptor for Cancer Therapy" AND "Use of Platelets as Therapeutic Delivery Vehicles"
GAITHERSBURG, Md., Oct. 3 /PRNewswire-USNewswire/ -- MaxCyte, Inc., a...
BETHESDA, Md., Oct. 3, 2008-A single injection of carboplatin – a chemotherapy drug commonly used to treat ovarian and lung cancer – can replace radiotherapy to cure a common type of testicular cancer, according to results presented at...
ECLIPSE Data Published in Anesthesia and Analgesia
FOR U.S. AUDIENCES ONLY
PARSIPPANY, N.J., Oct. 3, 2008--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today announced that ECLIPSE, the largest safety program to date comparing...
SYDNEY, Australia, Oct. 3 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis has announced that researchers will present 12 abstracts from its respiratory disease program at the 2008 European Respiratory Society Congress (ERS) being...
PV-10 Treatment for Metastatic Melanoma Well-Tolerated by Patients
Evidence of “Bystander Effect” Observed in Phase 1 Trial
KNOXVILLE, Tenn., Oct. 2, 2008--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a...
Journal: Scientists Identify Successful 'Anti' Antibiotic That May Help Curb Rising Staph Infections
ALBANY, Ore., Oct. 2 /PRNewswire/ -- For the second year in a row, students and athletes across the country are being hit by antibiotic resistant staph infections known as MRSA. In just over a week, two high school football players have died from...
Data Indicate Dual Modes of Action and Synergy with Chemotherapy
DALLAS, Oct. 2 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC:ACCP) (BULLETIN BOARD: ACCP) presented data this week from preclinical studies on Angiolix showing that by...
Data support the therapeutic potential of Amylin's integrated neurohormonal approach to obesity pharmacotherapy
SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) today announced that new data for its pipeline...
Company on Track to Submit NDA in the Fourth Quarter of 2008 Conference Call Begins Today at 9:00 A.M. Eastern Time
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, announced today positive...
Phase III Initiation Targeted Q1 2009
RESEARCH TRIANGLE PARK, N.C., Oct. 1, 2008--(BUSINESS WIRE)--Tranzyme Pharma today announced positive Phase IIb results for its first-in-class, highly potent and selective ghrelin agonist, TZP-101, for...
SCOTTSDALE, Ariz., Oct. 1, 2008--(BUSINESS WIRE)--Apthera, Inc. announced the optimized dose and schedule for its lead drug, NeuVax, in treating early-stage breast cancer patients to be used in Phase III clinical trials. Dr. George Peoples, Deputy...
CAMBRIDGE, Mass., Oct, 1, 2008--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in patients with...
- Results demonstrate the efficacy, safety and tolerability of RAPAFLO(TM) alone or in combination with treatments for erectile dysfunction -
CORONA, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) , a leading...
CAMBRIDGE, Mass., Oct, 1, 2008--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology™, announced today a paper...
THOUSAND OAKS, Calif., Sep 30, 2008 (BUSINESS WIRE) -- Amgen Inc., (NASDAQ: AMGN) announced it has received a summary of preliminary results from the Cochrane Collaboration's independent meta-analysis of patient-level data from previously conducted,...
HALIFAX, Oct. 1 /PRNewswire/ -- ImmunoVaccine Technologies' (IVT) patented depot vaccine formulation, DepoVax(TM) is showing positive pre-clinical results, with single-dose efficacy achieved in therapeutic cancer and several infectious disease...
Preclinical Results of New Somatropin Formulation Demonstrate Advantages Over Existing Once-Daily Product
NOTTINGHAM, England, October 1/PRNewswire/ -- Critical Pharmaceuticals, the Nottingham, UK-based speciality pharmaceuticals company, today...
ATLANTA, Oct. 1 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim month six...
Agency recommends no change in prescribing and use of statins
ROCKVILLE, Md., Sept. 29, 2008--A U.S. Food and Drug Administration's analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis...
Regression of total active lesion caused by wet AMD reported
SCOTTSDALE, Ariz., Sept. 28, 2008--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare AG announced that VEGF Trap-Eye achieved durable improvements...
More...
